Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rotigotine Add-On in Advanced Parkinson's Disease
NCT01723904Phase 3Completed
- Sponsor
- UCB
- Start
- Oct 2012
- Primary completion
- Mar 2013
- Modality
- Small Molecules
- Countries
- 5
01
Overview
A Phase 3 trial of rotigotine in Parkinson's disease (PD), sponsored by UCB. Started Oct 2012; status: completed.
02
Drugs
rotigotine
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on NCT01723904.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01723904.